Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Akuammine () and pseudoakuammigine () are indole alkaloids found in the seeds of the akuamma tree (). Both alkaloids are weak agonists of the mu opioid receptor (μOR); however, they produce minimal effects in animal models of antinociception. To probe the interactions of and at the opioid receptors, we have prepared a collection of 22 semisynthetic derivatives. Evaluation of this collection at the μOR and kappa opioid receptor (κOR) revealed structural-activity relationship trends and derivatives with improved potency at the μOR. Most notably, the introduction of a phenethyl moiety to the N1 of produces a 70-fold increase in potency and a 7-fold increase in selectivity for the μOR. The potency of this compound resulted in increased efficacy in the tail-flick and hot-plate assays of antinociception. The improved potency of these derivatives highlights the promise of exploring natural product scaffolds to probe the opioid receptors.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037270PMC
http://dx.doi.org/10.1021/acs.jmedchem.2c01707DOI Listing

Publication Analysis

Top Keywords

opioid receptor
8
opioid receptors
8
improved potency
8
potency
5
modified akuamma
4
akuamma alkaloids
4
alkaloids increased
4
increased potency
4
potency mu-opioid
4
mu-opioid receptor
4

Similar Publications

The legalization of cannabis for industrial and medicinal purposes has significantly expanded worldwide. This study delves into the analgesic potential toxicity study of chloroformic extract from the Moroccan L. () cultivar, Khardala (KH extract).

View Article and Find Full Text PDF

mGlu2 Receptors in the Basal Ganglia: A New Frontier in Addiction Therapy.

Front Biosci (Landmark Ed)

August 2025

Department of Biomedical Sciences, University of Missouri-Kansas City, School of Medicine, Kansas City, MO 64108, USA.

Glutamate is an important neurotransmitter in the mammalian brain. Among the receptors that glutamate interacts with is metabotropic glutamate (mGlu) receptor 2, a Gα-coupled receptor. These receptors are primarily located on glutamatergic nerve terminals and act as presynaptic autoreceptors to produce feedback inhibition of glutamate release.

View Article and Find Full Text PDF

Opioid analgesics are commonly prescribed to mitigate pathological pain. In addition to its analgesic effect, this pharmaceutical treatment program is well-known for its ability to induce adverse effects, including opioid-induced hyperalgesia (OIH) and analgesic tolerance. Thus, novel effective therapeutic strategies are urgently needed to improve opioid analgesia while mitigating side effects to ensure patient safety.

View Article and Find Full Text PDF

μ-Opioid receptor (MOR) agonists are a mainstay in acute pain management. However, they also produce adverse effects and are frequently misused, increasing susceptibility for opioid use disorder. Thus, a strategy for improving the safety of opioid analgesics is needed.

View Article and Find Full Text PDF

Introduction: Exposure to prescription opioids following traumatic injury can increase the risk of developing tolerance, persistent opioid use and opioid use disorder. The mechanisms underlying opioid tolerance or dependence are not well understood, and no biomarkers predict risk. Opioid exposure causes epigenetic modifications, including alterations in microRNA (miRNA) expression.

View Article and Find Full Text PDF